• OsALY4 Links m5C RNA Reading to Rice Stress Tolerance

  2026-09-13

  The reference study identifies OsALY4 as an m5C-mRNA reader that works with the RNA helicase OsAIP2 to regulate nuclear export of stress-related transcripts in rice. Its findings connect RNA modification recognition, nucleocytoplasmic transport, and chilling or salt adaptation, while highlighting compensatory roles for OsALY2 and OsALY6.

• Candidozyma auris in Guangzhou: Clades, Resistance, Virulenc

  2026-09-12

  A Guangzhou investigation integrates whole-genome sequencing with antifungal susceptibility, virulence phenotyping, biofilm assessment, and a Galleria mellonella model to distinguish two prevalent Candidozyma auris clades. Its findings link clade I to ERG11-associated resistance and stronger pathogenicity, while clade III shows enhanced biofilm formation, providing a framework for regional surveillance and infection-control research.

• DAPT (GSI-IX) in Human Neuron Assays

  2026-09-11

  DAPT (GSI-IX) is a selective γ-secretase inhibitor for dissecting APP processing and Notch signaling in advanced cell models. This article explains how to integrate it into validated human iPSC-derived sensory-neuron assays for stronger causal interpretation of neuronal and latent-infection phenotypes.

• Sodium Citrate in SERS: A Control-First Framework

  2026-09-11

  Sodium citrate can shape pH, metal-ion availability, and analyte compatibility in SERS workflows, but it should not be confused with nanostructure geometry. This control-first framework translates a recent 3D gold nanocluster study into practical assay decisions and validation controls.

• Letrozole in Translational Breast Cancer Research

  2026-09-10

  Letrozole is a potent, reversible, non-steroidal aromatase inhibitor that enables researchers to connect estrogen biosynthesis with receptor biology, endocrine feedback, and translational biomarker strategy. This article outlines how to design reproducible studies, interpret aromatase inhibition in breast cancer research, and distinguish enzyme-level potency from clinically meaningful biological response.

• Hyperoside, DHX9, and R-Loop Resolution in URSA

  2026-09-10

  A 2026 study identifies DHX9-mediated R-loop resolution as a mechanistic link between hyperoside treatment, reduced endometrial stromal cell senescence, and improved decidualization in unexplained recurrent spontaneous abortion. Its integration of patient tissues, mouse models, and telomerase-immortalized human stromal cells provides a useful framework for studying how genome-associated stress affects endometrial receptivity.

• A 83-01: Selective ALK-5 Inhibitor Guide

  2026-09-09

  A 83-01 is a selective ALK-5 inhibitor that suppresses TGF-β-driven Smad-dependent transcription in biochemical and cellular assays. Its documented activity against ALK-4 and ALK-7, limited BMP interference at lower test concentration, and use in hESC trophoblast differentiation make it a practical research tool when assay context and vehicle controls are preserved.

• BCL6–ESM1 Immune Evasion in Hepatocellular Carcinoma

  2026-09-09

  The reference study identifies cancer-cell-derived BCL6 as a driver of hepatocellular carcinoma progression through suppression of tumor-infiltrating CD4+ T-cell activity. Its mechanistic model links BCL6 to reduced inflammatory chemokines and increased ESM1, providing a framework for studying immune evasion and for designing complementary tumor-monitoring workflows.

• Pemetrexed Workflows for Mechanism-Guided Cancer Assays

  2026-09-08

  Build reproducible antifolate assays with pemetrexed disodium by aligning concentration, exposure time, and cell-state controls. The workflow also connects folate-pathway inhibition with homologous-recombination phenotypes in non-small cell lung carcinoma research and malignant mesothelioma models.

• SCH772984: ERK1/2 Inhibitor Workflow Guide

  2026-09-08

  Build a practical SCH772984 workflow for dissecting ERK signaling, tumor-cell dependence, and radiosensitization hypotheses. The guide connects pathway pharmacology with the Ang II–HIF-1α–HILPDA ferroptosis framework while separating established product performance from testable applications in nasopharyngeal carcinoma.

• Cassava A20/AN1 Genes Under Multiple Abiotic Stresses

  2026-09-07

  This study functionally characterizes three cassava A20/AN1 genes—Metip4, Metip8, and Metip11—across drought, salinity, temperature, and metal stresses. By combining gene prediction, interaction assays, heterologous transgenics, virus-induced gene silencing, physiological measurements, and transcriptomics, the authors show both shared stress-protective functions and gene-specific responses.

• MG-132: From Proteasome Stress to Translation

  2026-09-07

  MG-132, also known as Z-LLL-al, is more than a cytotoxicity reagent: it is a cell-permeable probe for testing how proteasome-dependent protein turnover shapes apoptosis, cell-cycle control, oxidative stress, and p53 biology. This thought-leadership article connects MG-132 pharmacology with findings from the MLF2–USP7–p53 colorectal cancer study and provides a translational framework for using the compound without overstating what proteasome inhibition can prove.

• Ribonuclease R for Circular RNA Workflows

  2026-09-05

  Ribonuclease R (RNase R) (20 U/μL) enables selective linear RNA depletion for circular RNA enrichment, validation, and sequencing workflows. This guide connects practical digestion controls with the circ_0042103/TAF15/NER findings in pulpitis research.

• Ertugliflozin (PF-04971729) Research Workflows

  2026-09-04

  Build reproducible renal glucose transport, diabetes mellitus, cardiovascular, and mucosal-barrier studies with the highly selective SGLT2 inhibitor Ertugliflozin. This guide connects practical dosing and assay setup with the VERTIS CV evidence while separating translational findings from exploratory preclinical applications.

• Prednisone Workflows for PBL Immunosuppression

  2026-09-04

  Prednisone is a defined synthetic corticosteroid for modeling lymphocyte suppression, G1 arrest, IL-2 pathway changes, and apoptosis with controlled exposure variables. This practical guide connects cell-based workflows with digestive-metabolomics quality principles while clearly separating established evidence from assay-development recommendations.

8036 records 1/536 page Next 12345 下5页 Last page